The influence of body weight of patients with chronic plaque psoriasis on biological treatment response

被引：14
作者：
Kisielnicka, Anna [1 ]
Szczerkowska-Dobosz, Aneta [2 ]
Nowicki, Roman J. [2 ]
机构：
[1] Med Univ Gdansk, Student Dermatol Soc, Gdansk, Poland
[2] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, 7 Debinki St, Gdansk 80211, Poland
来源：
POSTEPY DERMATOLOGII I ALERGOLOGII | 2020年 / 37卷 / 02期
关键词：
psoriasis; biological treatment; body mass index; MASS INDEX; CLINICAL-RESPONSE; RISK-FACTORS; USTEKINUMAB; OBESITY; THERAPY; IMPACT; ETANERCEPT; ADALIMUMAB; SEVERITY;
D O I：
10.5114/ada.2020.94835
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Psoriasis is a chronic inflammatory disease of the skin. The new era of biological therapies initiated a shift in the definition of the disease therapeutic success, however, recent reports in the literature draw attention to the treatment-induced weight gain in psoriatic patients. Therefore, it is worth considering the body mass index influence on the biological treatment of chronic plaque psoriasis, seeing that it has manifold associations with the disease and may play an important role in clinical practice management.
引用
收藏
页码：168 / 173
页数：6
相关论文
共 34 条
[1]   The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial [J].
Al-Mutairi, Nawaf ;
Nour, Tarek .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (06) :749-756
[2]   Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy [J].
Bardazzi, F. ;
Balestri, R. ;
Baldi, E. ;
Antonucci, A. ;
De Tommaso, S. ;
Patrizi, A. .
DERMATOLOGIC THERAPY, 2010, 23 :S14-S19
[3]   Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? [J].
Barrea, Luigi ;
Balato, Nicola ;
Di Somma, Carolina ;
Macchia, Paolo Emidio ;
Napolitano, Maddalena ;
Savanelli, Maria Cristina ;
Esposito, Katherine ;
Colao, Annamaria ;
Savastano, Silvia .
JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
[4]   Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study [J].
Chiricozzi, A. ;
Zangrilli, A. ;
Bavetta, M. ;
Bianchi, L. ;
Chimenti, S. ;
Saraceno, R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) :304-311
[5]   Overweight and Weight Gain Predict Psoriasis Development in a Population-based Cohort [J].
Danielsen, Kjersti ;
Wilsgaard, Tom ;
Olsen, Anne Olaug ;
Furberg, Anne-Sofie .
ACTA DERMATO-VENEREOLOGICA, 2017, 97 (03) :332-339
[6]   Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis [J].
Di Lernia, Vito ;
Tasin, Laura ;
Pellicano, Riccardo ;
Zumiani, Giuseppe ;
Albertini, Giuseppe .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (06) :404-409
[7]   Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis [J].
Edson-Heredia, Emily ;
Sterling, Kimberly L. ;
Alatorre, Carlos I. ;
Carter, Gebra Cuyun ;
Paczkowski, Rosirene ;
Zarotsky, Victoria ;
Maeda-Chubachi, Tomoko .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (01) :18-23
[8]   Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3 [J].
Egeberg, Alexander ;
Wu, Jashin J. ;
Korman, Neil ;
Solomon, James A. ;
Goldblum, Orin ;
Zhao, Fangyi ;
Mallbris, Lotus .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) :104-+
[9]  
Ehsani Amir Houshang, 2016, Acta Med Iran, V54, P570
[10]   Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study [J].
Gisondi, P. ;
Conti, A. ;
Galdo, G. ;
Piaserico, S. ;
De Simone, C. ;
Girolomoni, G. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (05) :1124-1127
1234